Sartorius completes acquisition of Novasep’s chromatography division
Sales revenue forecast for 2022 updated due to acquisition
Sartorius announced that, through its subgroup Sartorius Stedim Biotech, it closed the acquisition of the Novasep chromatography division as of February 7, 2022, following approval by the U.S. Federal Trade Commission. The transaction had already been agreed upon at the beginning of 2021. The business acquired generated sales of around 40 million euros in 2020 at a double-digit profit margin; final figures for 2021 are not yet available. The majority of the approximately 100 employees work at the Pompey site in eastern France and some in the USA, China, and India.
The portfolio acquired comprises chromatography systems primarily suited for smaller biomolecules, such as oligonucleotides, peptides, and insulin, as well as innovative systems for continuous manufacturing of biologics. Since 2018, Novasep and Sartorius have also been jointly developing optimized systems for a membrane-based chromatography technology.
As the acquisition is expected to generate additional non-organic sales revenue growth of around 1 percentage point in 2022, Sartorius has updated its sales revenue forecast for the current year as follows: Consolidated sales revenue is now expected to increase by about 15 percent to 19 percent (previously about 14 percent to 18 percent), with non-organic growth from acquisitions projected to contribute about 2 percentage points (previously about 1 percentage point). The company’s underlying EBITDA margin remains forecasted at about 34 percent this year.
For the Bioprocess Solutions Division, the company now forecasts sales revenue growth of about 17 percent to 21 percent for 2022 (previously about 16 percent to 20 percent), with non-organic growth from acquisitions contributing around 2 percentage points (previously around 1 percentage point). The division’s underlying EBITDA margin is still expected to be around 36 percent. The 2022 forecasts for the Lab Products & Services Division remain unchanged: Accordingly, the company continues to project sales revenue growth of about 6 percent to 10 percent, including a non-organic growth contribution from acquisitions of around 1 percentage point, and an underlying EBITDA margin of around 26 percent for the division.
All forecasts are based on constant currencies.
Other news from the department business & finance
These products might interest you
New
Octave BIO MCC System by Tosoh
Holistic Multi-Column Chromatography Solution
Flexible operation from parallel batches through SMB to integrated continuous processing
ÄKTA™ by Cytiva
Efficient protein purification on a laboratory scale
Automated and flexible chromatography systems for your research
ÄKTA pure micro by Cytiva
Maximum separation performance with minimum sample volume
ÄKTA pure micro: Efficient solutions for micropreparative columns
ÄKTA™ pure by Cytiva
ÄKTA pure – Flexible and Intuitive Protein Purification System
The Design Allows You to Customize and Easily Upgrade Your System to Meet Your Research Applications
ÄKTA go by Cytiva
Effective protein separation in a small space
Compact FPLC system for precise and fast purification results
Industrial-scale Centrifugal Partition Chromatography platform by RotaChrom Technologies
Make the purification of your compounds of interests scalable and customizable with CPC instruments
RotaChrom brings high R&D potential, reliability and agility to CRO and CDMO in the pharma industry
HPTLC PRO by CAMAG
Fully Automated HPTLC Sample Analysis and Evaluation System for Routine Quality Control
Exploit the full potential of High-Performance Thin-Layer Chromatography
AZURA® by KNAUER
Separate Molecules Continuously Using SMB Chromatography
Perfect Separation Conditions, Unmodified Sample Material and Low Costs
FPLC by KNAUER
Flexible and Modular: The Complete FPLC Solution for All Types of Protein Purification
The Powerful, Flexible FPLC System for Purification Processes the Way You Want Them
HPTLC by CAMAG
HPTLC systems for qualitative and quantitative analyses
Maximum flexibility for your specific analytical requirements
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic World Chromatography
Chromatography enables us to separate, identify and thus understand complex substances. Whether in the food industry, pharmaceutical research or environmental analysis - chromatography opens up a treasure trove of information about the composition and quality of our samples. Discover the fascinating world of chromatography!
Topic World Chromatography
Chromatography enables us to separate, identify and thus understand complex substances. Whether in the food industry, pharmaceutical research or environmental analysis - chromatography opens up a treasure trove of information about the composition and quality of our samples. Discover the fascinating world of chromatography!
